Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/38196| Title: | InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) plus 5-fluorouracil (5-FU) vs carboplatin (C) plus weekly paclitaxel (P) in patients (pts) with inoperable locally recurrent (ILR) or metastatic treatment naive disease - An International Rare Cancers Initiative (IRCI) trial. | Authors: | Glynne-Jones R.;Bridgewater J.;Falk S.;Arnold D.;Cunningham D.;Rao S.;Sclafani F.;Eng C.;Gronlie Guren M.;Adams R.A.;Benson A.;Sebag-Montefiore D.;Segelov E. ;Bryant A.;Peckitt C.;Roy A.;Seymour M.T.;Welch J.;Saunders M.P.;Muirhead R. | Monash Health Department(s): | Oncology | Institution: | (Rao, Bryant) GI Unit, Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom (Sclafani) Medicine-GI & Lymphoma Unit, Institute of Cancer Research/Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (Eng) Department of Gastrointestinal Medical Oncology, M. D. Anderson Cancer Center, TX, Houston, United States (Gronlie Guren) GI Unit, Oslo University Hospital, Oslo, Norway (Adams) Division of Cancer and Genetics, Cardiff University, Cardiff, United Kingdom (Benson) Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, United States (Sebag-Montefiore) GI Unit, University of Leeds, Leeds, United Kingdom (Segelov) Oncology, Monash Medical Centre, Clayton, Australia (Peckitt) R&D, Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom (Roy) GI Unit, Flinders Centre for Innovation in Cancer, Bedford Park, Australia (Seymour) Medical Oncology, St. James's University Hospital Leeds, Leeds, United Kingdom (Welch) Center for Global Health, NY, NY, United States (Saunders) GI Unit, Christie NHS Foundation Trust, Manchester, United Kingdom (Muirhead) Oncology, Churchill Hospital, Oxford, United Kingdom (Bridgewater) Oncology, University College London Hospitals, London, United Kingdom (Falk) Bristol Haematology and Cancer Centre, Bristol University Hospitals NHS Foundation Trust, Bristol, United Kingdom (Glynne-Jones) Radiotherapy, Mount Vernon Cancer Centre, Northwood, United Kingdom (Arnold) 2. Med. Abteilung, Asklepios Klinik Altona, Hamburg, Germany (Cunningham) Medicine, Institute of Cancer Research/Royal Marsden NHS Foundation Trust, Sutton, United Kingdom | Issue Date: | 18-Mar-2020 | Copyright year: | 2018 | Publisher: | NLM (Medline) | Place of publication: | United Kingdom | Publication information: | Annals of oncology : official journal of the European Society for Medical Oncology. 29 (Supplement 8) (pp viii715-viii716), 2018. Date of Publication: 01 Oct 2018. | Journal: | Annals of Oncology | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1093/annonc/mdy424.022 | PubMed URL: | 32137981 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32137981] | ISSN: | 1569-8041 (electronic) | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/38196 | Type: | Article | Subjects: | phase 2 carboplatin cisplatin fluorouracil paclitaxel advanced cancer anus cancer cancer recurrence |
Type of Clinical Study or Trial: | Randomised controlled trial |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.